期刊文献+

Caco-2细胞在药物研究中的应用进展

Development of Caco-2 cell model in drug researches
下载PDF
导出
摘要 目的Caco-2细胞模型特征及其在药物研究中的应用。方法概述了近年来Caco-2细胞模型在药物吸收机制、高通量筛选、药物相互作用、代谢及在药物剂型开发中应用情况。结果Caco-2细胞模型与整体吸收具有良好的相关性,可预测药物在体内的吸收、代谢规律。结论Caco-2细胞模型是药物体外研究的良好工具。 OBJECTIVE To introduce the characteristics of Caco-2 cell model and its development in drug researches. METHODS Caco-2 cell model is widely used in the researches on drug absorption mechanism,high throughput screening,interaction and metabolism. It is also applied in the study on pharmaceutics. RESULTS The caco-2 cell model has a good correlation to the data that was obtained in vivo. It can be used to predict the absorption and metabolism of drug in vivo. CONCLUSION Caco-2 cell model is an effective tool for the research of drug in vitro.
作者 刘向峰 李娜
机构地区 临沂市人民医院
出处 《齐鲁药事》 2007年第5期293-295,共3页 qilu pharmaceutical affairs
关键词 CACO-2细胞模型 体外吸收 代谢 应用 Caco-2 cell model absorption metabolism application
  • 相关文献

参考文献22

二级参考文献112

  • 1关溯,陈孝,黄民.Caco-2细胞模型——药物吸收研究的有效“工具”[J].中国药理学通报,2004,20(6):609-614. 被引量:38
  • 2陆泽华,杨易灿.补骨脂素加紫外光照对人白血病细胞株的抑制作用[J].中国药理学报,1993,14(A00). 被引量:9
  • 3赵福芹,王爱莲,王林.中药制剂中丹参素的兔体内分布研究[J].中国药学杂志,1994,29(5):291-293. 被引量:21
  • 4[1]Pantazis P, Earuj JA, Kozielski AJ, et al. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro [J]. Cancer Res, 1993,53(7) :1577 - 1582.
  • 5[2]Sands H, Mishra A, Stoeckler JD, et al. Preclinical activity of an iv formulation of rubitecan in IDD-PTM against human solid tumor xenografts [ J ]. Anticancer Drugs, 2002,13 (9): 965 - 975.
  • 6[3]Zhong DF, Li K, Xu JH, et al. Pharmacokinetics of 9-nitro-20 (S) -camptothecin in rats [ J ]. Acta Pharmacol Sin, 2003,24 (3) :256 - 262.
  • 7[4]Creemers GJ, Gervits CJH, Eckhardt J. Phase Ⅰ and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors [J].J Clin Oncol, 1997,15(3) :1087 - 1090.
  • 8[5]Chu XY, Suzuki H, Ueda K, et al. Active efflux of CPT-11 and its metabolites in human KB-derived cell lines[J]. J Pharmacol Exp Ther , 1999,288(2) :735 -741.
  • 9[6]Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport[J]. Adv DrugDeliv Rev, 2001,46(1 -3):27 -43.
  • 10[7]Hu M, Chen J, Zhu Y, et al. Mechanism and kinetics of transcellular transport of a new lactam antibiotic loracarbef across an human intestinal epithelial model system (Caco-2) [J]. PharmRes, 1994,11(12):1405-1413.

共引文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部